Source link : https://www.newshealth.biz/health-news/more-weight-loss-with-anti-obesity-meds-and-hormone-therapy/
DENVER — Postmenopausal women who receive hormone therapy show significantly greater weight loss when treated with the glucagon-like peptide 1 (GLP-1) receptor agonist drug semaglutide than those who do not receive hormone therapy, in a preliminary but notable study suggesting that menopause, itself, may reduce women’s responses to the highly popular anti-obesity drug. “To date, […]
Author : News Health
Publish date : 2024-05-23 13:00:40
Copyright for syndicated content belongs to the linked Source.